Physician

Nseobong I Ntukidem, MD

According to 2025 Medicare claims, Nseobong Ntukidem, MD (NPI: 1447474523) practices medical oncology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is COLUMBUS ONCOLOGY ASSOCIATES INC (NPI: 1790875656; TIN: 311211874) and primary practice location at 43082-7989.

Ntukidem's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 365 traditional Medicare patients, billed 70,536 HCPCS/CPT codes, and received $833,545 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 954 prescription claims across 167 beneficiaries totaling $2,381,750 in drug costs, led by Revlimid (Lenalidomide). 2023 DME data shows 33 claims. Open Payments data shows 4 records totaling $1,513. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,149,744 to $2,381,750. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	294	59,302	$635,250
2016	383	84,389	$754,531
2017	403	67,605	$718,905
2018	407	72,916	$714,409
2019	403	90,889	$1,113,736
2020	349	74,868	$1,078,635
2021	398	95,652	$1,345,372
2022	419	91,679	$1,017,370
2023	379	74,846	$807,634
2024	365	70,536	$833,545

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	210	1,305	$1,149,744
2016	196	1,226	$856,536
2017	188	1,189	$1,374,204
2018	188	1,117	$1,972,982
2019	197	1,109	$2,397,426
2020	165	992	$2,823,210
2021	176	969	$2,811,687
2022	168	967	$2,045,443
2023	170	949	$1,281,459
2024	167	954	$2,381,750

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	48	$16,388
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	14	$2,447
2022	N/R	15	$1,166
2023	N/R	33	$5,919
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	52	106	$134
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	39	39	$107
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	203	430	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	111	129	$56
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	148	265	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	29	812	$519,697
Xtandi	Enzalutamide	26	780	$369,799
Imbruvica	Ibrutinib	26	754	$354,939
Lenalidomide	Lenalidomide	20	560	$235,407
Eliquis	Apixaban	84	2,640	$51,586

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$1,513	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	2	$9,000	Cornerstone Specialty Network LLC

Explore More Providers

FAQ

What Medicare data is available for Nseobong I. Ntukidem, MD?

Tedicare shows public-source Medicare data for Nseobong I. Ntukidem, MD (NPI 1447474523), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nseobong I. Ntukidem, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nseobong I. Ntukidem, MD?

Nseobong I. Ntukidem, MD is linked to COLUMBUS ONCOLOGY ASSOCIATES INC (billing NPI 1790875656) in the available physician profile data.

Does Nseobong I. Ntukidem, MD have Open Payments data?

Nseobong I. Ntukidem, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.